Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| LifeMD, Inc.LFMD · Entity 6521 | Director | June 07, 2023 | September 01, 2023 |
| Quantum Computing Inc.QUBT · Entity 4589 | Director | January 26, 2023 | January 30, 2023 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
LifeMD, Inc.
Report date June 07, 2023 · Filed September 01, 2023 · Amendment
Amendment: balances below belong to this corrected disclosure, not necessarily a complete replacement of earlier positions.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | IndirectBy Mascot Capital Management, LLC | 164,000 |
Reported balance
After 2023-06-07 transaction · row 1
Amendment: may correct only part of an earlier disclosure.
1 source rowRow 1 · 2023-06-07 · Purchase · Acquired 24,500 · Balance 164,000 F1: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.17 to $2.20, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the numbers of shares purchased at each separate price with the ranges set forth. |
| Common StockSEC Table I · non-derivative | IndirectBy Mascot Capital Management, LLC | 213,465 |
Reported balance
After 2023-06-13 transaction · row 2
Amendment: may correct only part of an earlier disclosure.
1 source rowRow 2 · 2023-06-13 · Purchase · Acquired 49,465 · Balance 213,465 F2: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.59 to $2.95, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the numbers of shares purchased at each separate price with the ranges set forth. |
| Common StockSEC Table I · non-derivative | IndirectBy Aliunde Ltd. | 916,666 |
Reported balance
Holding disclosure · report date 2023-06-07 · row 3
Amendment: may correct only part of an earlier disclosure.
1 source rowRow 3 · Balance 916,666 |
Filing footnotes · ownership attribution and instrument terms
F1: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.17 to $2.20, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the numbers of shares purchased at each separate price with the ranges set forth.
F2: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.59 to $2.95, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the numbers of shares purchased at each separate price with the ranges set forth.
Quantum Computing Inc.
Report date January 26, 2023 · Filed January 30, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Options to purchase Common StockSEC Table II · derivative / convertible security · Conversion / exercise price $1.84 | Direct | 100,000 |
Reported balance
After 2023-01-26 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2023-01-26 · Grant · Acquired 100,000 · Balance 100,000 F1: These options were issued to Mr. Velge on January 26, 2023, pursuant to the Quantum Computing Inc. 2022 Equity and Incentive Plan and according to the terms of the employment agreement by and between Mr. Velge and the Issuer. These options vest in equal quarterly increments of 25,000 shares starting on March 31, 2023, June 30, 2023, September 30, 2023 and December 31, 2023, subject to Mr. Velge's continuing services for the Issuer in the capacity in which the grant was received on each applicable vesting date. |
Filing footnotes · ownership attribution and instrument terms
F1: These options were issued to Mr. Velge on January 26, 2023, pursuant to the Quantum Computing Inc. 2022 Equity and Incentive Plan and according to the terms of the employment agreement by and between Mr. Velge and the Issuer. These options vest in equal quarterly increments of 25,000 shares starting on March 31, 2023, June 30, 2023, September 30, 2023 and December 31, 2023, subject to Mr. Velge's continuing services for the Issuer in the capacity in which the grant was received on each applicable vesting date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 31, 2023 Filed Aug 31, 2023 23:00 UTC | LifeMD, Inc. LFMD · Entity 6521 | PurchaseCommon Stock | 60,000 | $3.93 | $235,800.00 |
DisclosureSEC source: 0001362118-23-000053 · primary_doc.xml · nonDerivative · entry 4 Velge Bertrand · CIK 0001758339 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Mascot Capital Management, LLC Disclosed balance after: 349,482 F3 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.86 to $3.99, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the numbers of shares purchased at each separate price with the ranges set forth. Read SEC document |
| August 30, 2023 Filed Aug 31, 2023 23:00 UTC | LifeMD, Inc. LFMD · Entity 6521 | PurchaseCommon Stock | 40,000 | $3.76 | $150,400.00 |
DisclosureSEC source: 0001362118-23-000053 · primary_doc.xml · nonDerivative · entry 3 Velge Bertrand · CIK 0001758339 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Mascot Capital Management, LLC Disclosed balance after: 289,482 Read SEC document |
| August 29, 2023 Filed Aug 31, 2023 23:00 UTC | LifeMD, Inc. LFMD · Entity 6521 | PurchaseCommon Stock | 32,072 | $3.58 | $114,817.76 |
DisclosureSEC source: 0001362118-23-000053 · primary_doc.xml · nonDerivative · entry 2 Velge Bertrand · CIK 0001758339 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Mascot Capital Management, LLC Disclosed balance after: 249,482 F2 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.54 to $3.60, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the numbers of shares purchased at each separate price with the ranges set forth. Read SEC document |
| June 14, 2023 Filed Jun 15, 2023 16:54 UTC | LifeMD, Inc. LFMD · Entity 6521 | PurchaseCommon Stock | 3,945 | $2.94 | $11,579.76 |
DisclosureSEC source: 0001362118-23-000040 · primary_doc.xml · nonDerivative · entry 1 Velge Bertrand · CIK 0001758339 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Mascot Capital Management, LLC Disclosed balance after: 212,310 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.905 to $2.999, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth. Read SEC document |
| June 13, 2023 Filed Jun 14, 2023 12:55 UTC | LifeMD, Inc. LFMD · Entity 6521 | PurchaseCommon Stock | 44,365 | $2.64 | $116,932.83 |
DisclosureSEC source: 0001362118-23-000038 · primary_doc.xml · nonDerivative · entry 2 Velge Bertrand · CIK 0001758339 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Mascot Capital Management, LLC Disclosed balance after: 208,365 F2 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.59 to $2.95, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth. Read SEC document |
| June 13, 2023 Filed Sep 1, 2023 11:38 UTC Amendment | LifeMD, Inc. LFMD · Entity 6521 | PurchaseCommon Stock | 49,465 | $2.64 | $130,374.90 |
DisclosureSEC source: 0001362118-23-000054 · primary_doc.xml · nonDerivative · entry 2 Velge Bertrand · CIK 0001758339 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Mascot Capital Management, LLC Disclosed balance after: 213,465 F2 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.59 to $2.95, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the numbers of shares purchased at each separate price with the ranges set forth. Read SEC document |
| June 07, 2023 Filed Jun 14, 2023 12:55 UTC | LifeMD, Inc. LFMD · Entity 6521 | PurchaseCommon Stock | 24,500 | $2.19 | $53,547.20 |
DisclosureSEC source: 0001362118-23-000038 · primary_doc.xml · nonDerivative · entry 1 Velge Bertrand · CIK 0001758339 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Mascot Capital Management, LLC Disclosed balance after: 164,000 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.17 to $2.20, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth. Read SEC document |
| June 07, 2023 Filed Sep 1, 2023 11:38 UTC Amendment | LifeMD, Inc. LFMD · Entity 6521 | PurchaseCommon Stock | 24,500 | $2.19 | $53,547.20 |
DisclosureSEC source: 0001362118-23-000054 · primary_doc.xml · nonDerivative · entry 1 Velge Bertrand · CIK 0001758339 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Mascot Capital Management, LLC Disclosed balance after: 164,000 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.17 to $2.20, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the numbers of shares purchased at each separate price with the ranges set forth. Read SEC document |
| June 06, 2023 Filed Jun 7, 2023 21:27 UTC | LifeMD, Inc. LFMD · Entity 6521 | PurchaseCommon Stock | 129,117 | $2.18 | $281,397.59 |
DisclosureSEC source: 0001362118-23-000036 · primary_doc.xml · nonDerivative · entry 2 Velge Bertrand · CIK 0001758339 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Mascot Capital Management, LLC Disclosed balance after: 139,500 F2 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.14 to $2.21, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth. Read SEC document |
| June 05, 2023 Filed Jun 7, 2023 21:27 UTC | LifeMD, Inc. LFMD · Entity 6521 | PurchaseCommon Stock | 10,383 | $2.17 | $22,480.23 |
DisclosureSEC source: 0001362118-23-000036 · primary_doc.xml · nonDerivative · entry 1 Velge Bertrand · CIK 0001758339 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Mascot Capital Management, LLC Disclosed balance after: 10,383 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.15 to $2.17, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth. Read SEC document |
| January 26, 2023 Filed Jan 30, 2023 22:24 UTC | Quantum Computing Inc. QUBT · Entity 4589 | GrantOptions to purchase Common Stock · Derivative | 100,000 | $0.00 Strike: $1.84 | $0.00 |
DisclosureSEC source: 0001213900-23-006084 · ownership.xml · derivative · entry 1 Velge Bertrand · CIK 0001758339 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires not disclosed F1 · shares: These options were issued to Mr. Velge on January 26, 2023, pursuant to the Quantum Computing Inc. 2022 Equity and Incentive Plan and according to the terms of the employment agreement by and between Mr. Velge and the Issuer. These options vest in equal quarterly increments of 25,000 shares starting on March 31, 2023, June 30, 2023, September 30, 2023 and December 31, 2023, subject to Mr. Velge's continuing services for the Issuer in the capacity in which the grant was received on each applicable vesting date. F1 · derivative.exercise_date: These options were issued to Mr. Velge on January 26, 2023, pursuant to the Quantum Computing Inc. 2022 Equity and Incentive Plan and according to the terms of the employment agreement by and between Mr. Velge and the Issuer. These options vest in equal quarterly increments of 25,000 shares starting on March 31, 2023, June 30, 2023, September 30, 2023 and December 31, 2023, subject to Mr. Velge's continuing services for the Issuer in the capacity in which the grant was received on each applicable vesting date. F1 · derivative.expiration_date: These options were issued to Mr. Velge on January 26, 2023, pursuant to the Quantum Computing Inc. 2022 Equity and Incentive Plan and according to the terms of the employment agreement by and between Mr. Velge and the Issuer. These options vest in equal quarterly increments of 25,000 shares starting on March 31, 2023, June 30, 2023, September 30, 2023 and December 31, 2023, subject to Mr. Velge's continuing services for the Issuer in the capacity in which the grant was received on each applicable vesting date. Read SEC document |
| November 22, 2022 Filed Aug 31, 2023 23:00 UTC | LifeMD, Inc. LFMD · Entity 6521 | GrantCommon Stock | 10,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001362118-23-000053 · primary_doc.xml · nonDerivative · entry 1 Velge Bertrand · CIK 0001758339 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Aliunde Ltd. Disclosed balance after: 926,666 F1 · price: The grant of restricted shares vested incrementally on December 31, 2022 (50%), March 31, 2023 (25%), and June 16, 2023 (25%). Read SEC document |
| October 17, 2022 Filed Oct 20, 2022 01:52 UTC | Quantum Computing Inc. QUBT · Entity 4589 | GrantOptions to purchase Common Stock · Derivative | 250,000 | $0.00 Strike: $2.37 | $0.00 |
DisclosureSEC source: 0001213900-22-065069 · ownership.xml · derivative · entry 2 Velge Bertrand · CIK 0001758339 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 450,000 Underlying: Common Stock · 250,000 shares Expires 2027-10-17 F2 · derivative.exercise_date: These options were issued to Mr. Velge on October 17, 2022 as a success bonus for the completion of the Issuer's merger with QPhoton, Inc., and pursuant to the Quantum Computing Inc. 2022 Equity and Incentive Plan. These options vest as follows: (i) 100,000 shares on June 16, 2022, (ii) 75,000 shares on September 30, 2022, and (iii) 75,000 shares on December 31, 2022. Read SEC document |
| October 17, 2022 Filed Oct 20, 2022 01:52 UTC | Quantum Computing Inc. QUBT · Entity 4589 | GrantOptions to purchase Common Stock · Derivative | 100,000 | $0.00 Strike: $2.37 | $0.00 |
DisclosureSEC source: 0001213900-22-065069 · ownership.xml · derivative · entry 1 Velge Bertrand · CIK 0001758339 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 200,000 Underlying: Common Stock · 100,000 shares Expires 2027-10-17 F1 · shares: These options were issued to Mr. Velge on October 17, 2022, pursuant to the Quantum Computing Inc. 2022 Equity and Incentive Plan and according to the terms of the employment agreement by and between Mr. Velge and the Issuer. These options vest in equal quarterly increments of 25,000 shares on March 31, 2022, June 30, 2022, September 30, 2022 and December 31, 2022, subject to Mr. Velge's continuing services for the Issuer in the capacity in which the grant was received on each applicable vesting date. F1 · derivative.exercise_date: These options were issued to Mr. Velge on October 17, 2022, pursuant to the Quantum Computing Inc. 2022 Equity and Incentive Plan and according to the terms of the employment agreement by and between Mr. Velge and the Issuer. These options vest in equal quarterly increments of 25,000 shares on March 31, 2022, June 30, 2022, September 30, 2022 and December 31, 2022, subject to Mr. Velge's continuing services for the Issuer in the capacity in which the grant was received on each applicable vesting date. Read SEC document |
| December 07, 2021 Filed Dec 8, 2021 16:39 UTC | LifeMD, Inc. LFMD · Entity 6521 | PurchaseCommon Stock | 25,000 | $4.54 | $113,500.00 |
DisclosureSEC source: 0001362118-21-000052 · primary_doc.xml · nonDerivative · entry 1 Velge Bertrand · CIK 0001758339 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Aliunde LLC Disclosed balance after: 916,666 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.44 to $4.58, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth. Read SEC document |
| December 03, 2021 Filed Dec 7, 2021 20:52 UTC | LifeMD, Inc. LFMD · Entity 6521 | PurchaseCommon Stock | 110,000 | $3.91 | $430,100.00 |
DisclosureSEC source: 0001362118-21-000051 · primary_doc.xml · nonDerivative · entry 5 Velge Bertrand · CIK 0001758339 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Aliunde LLC Disclosed balance after: 891,666 F2 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.80 to $4.02, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth. Read SEC document |
| March 31, 2021 Filed Dec 7, 2021 20:52 UTC | LifeMD, Inc. LFMD · Entity 6521 | GrantStock Option (Right to Buy) · Derivative | 2,500 | $0.00 Strike: $11.98 | $0.00 |
DisclosureSEC source: 0001362118-21-000051 · primary_doc.xml · derivative · entry 14 Velge Bertrand · CIK 0001758339 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,500 Underlying: Common Stock · 2,500 shares Expires 2026-03-31 F4 · shares: Issued as director's compensation. Read SEC document |
| December 31, 2020 Filed Dec 7, 2021 20:52 UTC | LifeMD, Inc. LFMD · Entity 6521 | GrantStock Option (Right to Buy) · Derivative | 2,500 | $0.00 Strike: $7.00 | $0.00 |
DisclosureSEC source: 0001362118-21-000051 · primary_doc.xml · derivative · entry 13 Velge Bertrand · CIK 0001758339 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,500 Underlying: Common Stock · 2,500 shares Expires 2025-12-31 F4 · shares: Issued as director's compensation. Read SEC document |
| September 30, 2020 Filed Dec 7, 2021 20:52 UTC | LifeMD, Inc. LFMD · Entity 6521 | GrantStock Option (Right to Buy) · Derivative | 2,500 | $0.00 Strike: $7.95 | $0.00 |
DisclosureSEC source: 0001362118-21-000051 · primary_doc.xml · derivative · entry 12 Velge Bertrand · CIK 0001758339 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,500 Underlying: Common Stock · 2,500 shares Expires 2025-09-30 F4 · shares: Issued as director's compensation. Read SEC document |
| September 22, 2020 Filed Dec 7, 2021 20:52 UTC | LifeMD, Inc. LFMD · Entity 6521 | GrantWarrants to Purchase Common Stock · Derivative | 100,000 | $0.00 Strike: $4.65 | $0.00 |
DisclosureSEC source: 0001362118-21-000051 · primary_doc.xml · derivative · entry 11 Velge Bertrand · CIK 0001758339 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2024-09-22 Read SEC document |
| September 22, 2020 Filed Dec 7, 2021 20:52 UTC | LifeMD, Inc. LFMD · Entity 6521 | PurchaseCommon Stock | 96,923 | $0.65 | $62,999.95 |
DisclosureSEC source: 0001362118-21-000051 · primary_doc.xml · nonDerivative · entry 4 Velge Bertrand · CIK 0001758339 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 781,666 F3 · price: Issued in connection with Exchange Agreement dated September 22, 2020 whereby shares of common stock and warrants were exchanged for outstanding debt. Read SEC document |
| August 05, 2020 Filed Dec 7, 2021 20:52 UTC | LifeMD, Inc. LFMD · Entity 6521 | GrantCommon Stock | 173,234 | $0.00 | $0.00 |
DisclosureSEC source: 0001362118-21-000051 · primary_doc.xml · nonDerivative · entry 3 Velge Bertrand · CIK 0001758339 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 684,743 F5 · shares: Issued pursuant to anti-dilution provisions contained in the Securities Purchase Agreement dated May 31, 2019. Read SEC document |
| June 30, 2020 Filed Dec 7, 2021 20:52 UTC | LifeMD, Inc. LFMD · Entity 6521 | GrantStock Option (Right to Buy) · Derivative | 2,500 | $0.00 Strike: $11.56 | $0.00 |
DisclosureSEC source: 0001362118-21-000051 · primary_doc.xml · derivative · entry 15 Velge Bertrand · CIK 0001758339 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,500 Underlying: Common Stock · 2,500 shares Expires 2026-06-30 F4 · shares: Issued as director's compensation. Read SEC document |
| June 30, 2020 Filed Dec 7, 2021 20:52 UTC | LifeMD, Inc. LFMD · Entity 6521 | GrantStock Option (Right to Buy) · Derivative | 2,500 | $0.00 Strike: $1.50 | $0.00 |
DisclosureSEC source: 0001362118-21-000051 · primary_doc.xml · derivative · entry 10 Velge Bertrand · CIK 0001758339 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,500 Underlying: Common Stock · 2,500 shares Expires 2025-06-30 F4 · shares: Issued as director's compensation. Read SEC document |
| April 15, 2020 Filed Dec 7, 2021 20:52 UTC | LifeMD, Inc. LFMD · Entity 6521 | PurchaseCommon Stock | 294,118 | $0.17 | $50,000.06 |
DisclosureSEC source: 0001362118-21-000051 · primary_doc.xml · nonDerivative · entry 2 Velge Bertrand · CIK 0001758339 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 511,509 Read SEC document |
| March 31, 2020 Filed Dec 7, 2021 20:52 UTC | LifeMD, Inc. LFMD · Entity 6521 | GrantStock Option (Right to Buy) · Derivative | 2,500 | $0.00 Strike: $1.20 | $0.00 |
DisclosureSEC source: 0001362118-21-000051 · primary_doc.xml · derivative · entry 9 Velge Bertrand · CIK 0001758339 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,500 Underlying: Common Stock · 2,500 shares Expires 2025-03-31 F4 · shares: Issued as director's compensation. Read SEC document |
| December 31, 2019 Filed Dec 7, 2021 20:52 UTC | LifeMD, Inc. LFMD · Entity 6521 | GrantStock Option (Right to Buy) · Derivative | 2,500 | $0.00 Strike: $1.15 | $0.00 |
DisclosureSEC source: 0001362118-21-000051 · primary_doc.xml · derivative · entry 8 Velge Bertrand · CIK 0001758339 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,500 Underlying: Common Stock · 2,500 shares Expires 2024-12-31 F4 · shares: Issued as director's compensation. Read SEC document |
| September 30, 2019 Filed Dec 7, 2021 20:52 UTC | LifeMD, Inc. LFMD · Entity 6521 | GrantStock Option (Right to Buy) · Derivative | 2,500 | $0.00 Strike: $1.15 | $0.00 |
DisclosureSEC source: 0001362118-21-000051 · primary_doc.xml · derivative · entry 7 Velge Bertrand · CIK 0001758339 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,500 Underlying: Common Stock · 2,500 shares Expires 2024-09-30 F4 · shares: Issued as director's compensation. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.